Lonza and InduPro signed a licensing agreement to support the advancement of innovative antibody–drug conjugate (ADC) therapies. According to Lonza…

Cholesterol-related heart disease remains the leading cause of death worldwide, and while doctors have more tools than ever to treat…

The UCI Health neurology team prepares the first patient to receive neural stem cell therapy in groundbreaking Huntington’s disease clinical…

John Crowley, CEO of the Biotechnology Innovation Organization (BIO), at the 2026 international conference in San Diego. [Biotechnology Innovation Organization]…

Allogeneic natural killer (NK) cells appear promising as an adoptive cell therapy (ACT) that targets cancer. They’re limited, however, by…

The manufacturing of weight loss drugs at large scale could get cheaper and more sustainable thanks to an engineered strain…

Human pluripotent stem cells (hPSCs) have long been viewed as one of regenerative medicine’s most promising raw materials. Now, as…

Ireland’s National Institute for Bioprocessing Research and Training (NIBRT) will help biopharma engineers hone their automation and AI skills as…

Medra's physical AI platform conducting experiments [Medra] As AI infrastructure for drug discovery continues to proliferate with reasoning workflows capable…

Drew Weissman, MD, PhD Professor in Vaccine ResearchPenn Medicine Panelist Drew Weissman, MD, PhD Drew Weissman, MD, PhD, is a…